Across TCGA pan-cancer cohorts, RPL15P20 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL15P20’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL15P20 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL15P20 is over-expressed in tumor, although a few such as BRCA and STAD show the opposite, repressed pattern.

COAD, LIHC, and KIRP are the cancer types where RPL15P20 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL15P20 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.633	<.001	6	view →
LIHC	All	II,III,IV	+0.129	.001	4	view →
KIRP	Female	II,III,IV	+0.314	.038	3	view →
BRCA	Female	All	−0.061	.037	2	view →
STAD	All	All	−0.184	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPL15P20 RNA expression & survival · all RPL15P20 data types